Yellow Fever Vaccination: The Potential of Dose-Sparing to Increase Vaccine Supply and Availability
This report aimed to evaluate whether dose-sparing, possibly through the intradermal (ID) route, could improve the availability of yellow fever vaccine globally. The report identifies and discusses potential benefits, possible obstacles, and associated costs of dose-sparing as a vaccine delivery strategy. It also assesses settings where dose-sparing would be most appropriate and to what extent novel ID delivery devices would help facilitate its successful implementation.
» Download file (English)
2.04 MB PDF (Located at www.path.org)
Diseases/vaccines: Not disease/vaccine specific